CFA
BIVV

CT Financial Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

CT Financial Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$24.9K Buy
+457
New +$22.5K 0.02% 335

Other funds holding BIVV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CT Financial Advisors's BIVV Position: Q1 2017 in Review

CT Financial Advisors opened a new position in Bioverativ Inc. Common Stock (BIVV) in Q1 2017: 457 shares worth $24.9K. The stake represents 0.02% of the portfolio and ranks #335 among its holdings.

467 funds tracked by Wall St. Rank hold BIVV as of Q1 2017.

  • CT Financial Advisors held 457 shares of Bioverativ Inc. Common Stock worth $24.9K as of Q1 2017.
  • Bioverativ Inc. Common Stock was a new CT Financial Advisors position in Q1 2017.
  • Bioverativ Inc. Common Stock made up 0.02% of CT Financial Advisors's portfolio in Q1 2017, its #335 holding.
  • 467 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.